$CTGO
Contango ORE, Inc.

2021 Q2 Form 10-K Financial Statement

#000143774921021206 Filed on August 31, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 2020 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.088M $10.36M $2.131M
YoY Change -2.0% 85.21% 67.47%
% of Gross Profit
Research & Development $109.2K $299.9K
YoY Change -0.03%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $2.197M $10.66M $2.131M
YoY Change 3.12% 90.57% 67.47%
Operating Profit
YoY Change
Interest Expense $50.49K $35.83M -$418.9K
YoY Change -112.05% -1083.06% -52.21%
% of Operating Profit
Other Income/Expense, Net $35.83M
YoY Change -1083.07%
Pretax Income -$2.147M $25.17M -$2.550M
YoY Change -15.8% -372.41% 18.65%
Income Tax -$297.7K $1.302M
% Of Pretax Income 5.17%
Net Earnings -$1.849M $23.87M -$2.550M
YoY Change -27.47% -358.32% 18.65%
Net Earnings / Revenue
Basic Earnings Per Share $3.82
Diluted Earnings Per Share -$297.3K $3.82 -$389.0K
COMMON SHARES
Basic Shares Outstanding 6.251M 6.557M
Diluted Shares Outstanding 6.254M

Balance Sheet

Concept 2021 Q2 2021 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.22M $35.22M $3.012M
YoY Change 1069.37% 1069.37% -64.98%
Cash & Equivalents $35.22M $3.012M
Short-Term Investments
Other Short-Term Assets $515.6K $515.6K $72.24K
YoY Change 613.79% 613.79% -55.19%
Inventory
Prepaid Expenses $515.6K $72.24K
Receivables
Other Receivables
Total Short-Term Assets $35.93M $35.93M $3.084M
YoY Change 1065.13% 1065.13% -64.8%
LONG-TERM ASSETS
Property, Plant & Equipment $36.53K $36.53K
YoY Change -8.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change
Other Assets $36.53K
YoY Change
Total Long-Term Assets $36.53K $36.53K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $35.93M $35.93M $3.084M
Total Long-Term Assets $36.53K $36.53K
Total Assets $35.97M $35.97M $3.084M
YoY Change 1066.31% 1066.31% -64.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.27K $26.27K $83.16K
YoY Change -68.41% -68.41% 16.45%
Accrued Expenses $195.8K $195.8K $1.006M
YoY Change -80.54% -80.54% 189.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $222.1K $222.1K $1.089M
YoY Change -79.61% -79.61% 159.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.200M $1.200M
YoY Change 0.0%
Total Long-Term Liabilities $1.200M $1.200M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $222.1K $222.1K $1.089M
Total Long-Term Liabilities $1.200M $1.200M
Total Liabilities $1.422M $1.422M $1.089M
YoY Change 30.54% 30.54% 159.82%
SHAREHOLDERS EQUITY
Retained Earnings -$35.03M -$58.90M
YoY Change -40.53% 18.61%
Common Stock $69.58M $61.37M
YoY Change 13.38% 5.81%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $476.7K
YoY Change -100.0%
Treasury Stock Shares $0.00 $32.87K
Shareholders Equity $34.55M $34.55M $1.995M
YoY Change
Total Liabilities & Shareholders Equity $35.97M $35.97M $3.084M
YoY Change 1066.31% 1066.31% -64.8%

Cashflow Statement

Concept 2021 Q2 2021 2020 Q2
OPERATING ACTIVITIES
Net Income -$1.849M $23.87M -$2.550M
YoY Change -27.47% -358.32% 18.65%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$1.979M -$8.378M -$161.7K
YoY Change 1123.42% 501.87% -34.47%
INVESTING ACTIVITIES
Capital Expenditures -$36.53K $36.53K
YoY Change
Acquisitions $0.00
YoY Change
Other Investing Activities $50.00K $27.39M -$420.0K
YoY Change -111.9% -836.26% -54.84%
Cash From Investing Activities $13.47K $27.35M -$420.0K
YoY Change -103.21% -835.27% -54.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.95M 13.23M 0.000
YoY Change -2876.51%
NET CHANGE
Cash From Operating Activities -1.979M -8.378M -161.7K
Cash From Investing Activities 13.47K 27.35M -420.0K
Cash From Financing Activities 10.95M 13.23M 0.000
Net Change In Cash 8.981M 32.21M -581.7K
YoY Change -1643.78% -676.31% -50.57%
FREE CASH FLOW
Cash From Operating Activities -$1.979M -$8.378M -$161.7K
Capital Expenditures -$36.53K $36.53K
Free Cash Flow -$1.942M -$8.415M
YoY Change 504.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 ctgo Adjustments To Additional Paid In Capital Treasury Shares Withheld For Employee Taxes
AdjustmentsToAdditionalPaidInCapitalTreasurySharesWithheldForEmployeeTaxes
-476672
CY2021 ctgo Adjustments To Additional Paid In Capital Treasury Shares Withheld For Employee Taxes
AdjustmentsToAdditionalPaidInCapitalTreasurySharesWithheldForEmployeeTaxes
-876551
CY2021Q2 ctgo Advance Royalty Reimbursement Noncurrent
AdvanceRoyaltyReimbursementNoncurrent
1200000
CY2020Q2 ctgo Advance Royalty Reimbursement Noncurrent
AdvanceRoyaltyReimbursementNoncurrent
CY2019Q1 ctgo Contingent Salary And Compensation Retention Agreement
ContingentSalaryAndCompensationRetentionAgreement
1500000
CY2021Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
6016386
CY2020Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
7143550
CY2021 ctgo Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
472
CY2020 ctgo Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
-6811
CY2021 ctgo Effective Income Tax Rate Reconciliation Restricted Stock Shortfall Amount
EffectiveIncomeTaxRateReconciliationRestrictedStockShortfallAmount
162750
CY2020 ctgo Effective Income Tax Rate Reconciliation Restricted Stock Shortfall Amount
EffectiveIncomeTaxRateReconciliationRestrictedStockShortfallAmount
CY2021 ctgo Effective Income Tax Rate Reconciliation Return To Provision Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount
-161474
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021 dei Document Type
DocumentType
10-K
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6685746
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Public Float
EntityPublicFloat
58269356
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020 ctgo Effective Income Tax Rate Reconciliation Return To Provision Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount
CY2021 ctgo Effective Income Tax Rate Reconciliation Transaction Costs Amount
EffectiveIncomeTaxRateReconciliationTransactionCostsAmount
73182
CY2020 ctgo Effective Income Tax Rate Reconciliation Transaction Costs Amount
EffectiveIncomeTaxRateReconciliationTransactionCostsAmount
CY2021 ctgo Increase Decrease In Advance Royalty Reimbursement
IncreaseDecreaseInAdvanceRoyaltyReimbursement
1200000
CY2020 ctgo Increase Decrease In Advance Royalty Reimbursement
IncreaseDecreaseInAdvanceRoyaltyReimbursement
CY2021 ctgo Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
14111410
CY2020 ctgo Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
CY2020Q4 ctgo Rights Agreement Exercise Price
RightsAgreementExercisePrice
100
CY2020Q4 ctgo Rights Agreement Number Of Preferred Stock Issuable Per Right
RightsAgreementNumberOfPreferredStockIssuablePerRight
0.001
CY2020Q4 ctgo Rights Agreement Term
RightsAgreementTerm
P1Y
CY2021 ctgo Stock Issued During Period Value New Issues And Treasury Stock Reissued
StockIssuedDuringPeriodValueNewIssuesAndTreasuryStockReissued
14275004
CY2021 ctgo Stock Received And Retired From Sale Of Investment Value
StockReceivedAndRetiredFromSaleOfInvestmentValue
8442857
CY2020 ctgo Stock Received And Retired From Sale Of Investment Value
StockReceivedAndRetiredFromSaleOfInvestmentValue
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.01 per share
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
26268
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
83158
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
195837
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1006237
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
69509606
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61302249
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3368916
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3892883
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
163594
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3892883
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3368916
CY2021Q2 us-gaap Assets
Assets
35970880
CY2020Q2 us-gaap Assets
Assets
3084162
CY2021Q2 us-gaap Assets Current
AssetsCurrent
35934349
CY2020Q2 us-gaap Assets Current
AssetsCurrent
3084162
CY2021Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
36531
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
CY2021 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">2.</div> Basis of Presentation</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America.&nbsp; These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. The Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;expects that its ongoing cash requirements will&nbsp;be related to exploration expenses on its <div style="display: inline; font-style: italic; font: inherit;">100%</div> owned State Mining claims, general and administration expenses, and funding cash calls from the Joint Venture Company. The Company's sources of cash have historically been from common stock offerings.&nbsp; The Company believes that its current cash balances will be sufficient to meet its working capital requirements for the next <div style="display: inline; font-style: italic; font: inherit;">twelve</div> months from the date of this report.</div></div></div>
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35220588
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3011918
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3011918
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8600658
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35220588
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32208670
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5588740
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6675746
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6590113
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6675746
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6557239
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
66757
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
65901
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
10662178
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
5594995
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
915234
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1301874
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
386640
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4054750
CY2021Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
1846393
CY2020Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
4370574
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1900850
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1161254
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9763629
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16730128
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.82
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.82
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
77910
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-202421
CY2021 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
39692857
CY2020 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2021 us-gaap Exploration Expense
ExplorationExpense
299897
CY2020 us-gaap Exploration Expense
ExplorationExpense
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3720000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1301874
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10362281
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5594995
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25170997
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9240041
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3861252
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-6966500
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2361794
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5285909
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1940409
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2829625
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-616995
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1500000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2021Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
198126
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-867290
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
670106
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-198126
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
443391
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-88951
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
1570
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
74954
CY2021Q2 us-gaap Liabilities
Liabilities
1422105
CY2020Q2 us-gaap Liabilities
Liabilities
1089395
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35970880
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3084162
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
222105
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1089395
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1200000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
0
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13234859
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-476672
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27352217
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3720000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8378406
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1392068
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23869123
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9240041
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
35833175
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3645046
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
876551
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
476672
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3861252
CY2020 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3720000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36531
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
515635
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
72244
CY2021 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
31250000
CY2020 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36531
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35027588
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58896711
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3892883
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
3368916
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7.42
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
83425642
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1994767
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
34548775
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
32874
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
476672
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Management Estimates.</div>&nbsp;The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div>
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-7000000
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2767
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6253661
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6475795
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6250894
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6475795

Files In Submission

Name View Source Status
0001437749-21-021206-index-headers.html Edgar Link pending
0001437749-21-021206-index.html Edgar Link pending
0001437749-21-021206.txt Edgar Link pending
0001437749-21-021206-xbrl.zip Edgar Link pending
chiefdannygoldinsoils.jpg Edgar Link pending
conta20210630b_10k.htm Edgar Link pending
ctgo-20210630.xml Edgar Link completed
ctgo-20210630.xsd Edgar Link pending
ctgo-20210630_cal.xml Edgar Link unprocessable
ctgo-20210630_def.xml Edgar Link unprocessable
ctgo-20210630_lab.xml Edgar Link unprocessable
ctgo-20210630_pre.xml Edgar Link unprocessable
ex_273586.htm Edgar Link pending
ex_273587.htm Edgar Link pending
ex_273588.htm Edgar Link pending
ex_273589.htm Edgar Link pending
ex_273590.htm Edgar Link pending
ex_273591.htm Edgar Link pending
ex_273592.htm Edgar Link pending
ex_273593.htm Edgar Link pending
ex_273594.htm Edgar Link pending
ex_280056.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image01.jpg Edgar Link pending
in-filldrillholesmap.jpg Edgar Link pending
locationofassetsmap-2021.jpg Edgar Link pending
manhchohdrillingprogram2021-.jpg Edgar Link pending
mapofhonaholes2019program-up.jpg Edgar Link pending
peakgoldandtargets.jpg Edgar Link pending
programeastpeakandnorths.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
shamrockprospectmap2021.jpg Edgar Link pending
Show.js Edgar Link pending